Scienceindustries Advocates for Swiss-US Free Trade Agreement Amid New Tariffs
Scienceindustries, the association representing Switzerland's chemical, pharma, and life sciences sectors, is advocating for a bilateral economic agreement with the United States. This call comes in response to the U.S. imposing an additional 12.5% tariff under Section 301 measures. The association expressed disappointment that the U.S. Trade Representative did not adequately consider Switzerland's legal framework or its measures against forced labor. Despite this, Scienceindustries views the outcomes of a recent Joint Statement as a positive step towards continued dialogue. The association emphasizes that tariffs increase product costs, disrupt supply chains, and ultimately impact businesses, consumers, and patients. It highlights the importance of a bilateral agreement, noting that the U.S. is Switzerland's second-largest export market after the EU. While pharmaceuticals and related raw materials are exempt from these tariffs, the increased costs will affect transatlantic supply chains, impacting U.S. co... 
